Latest filing published 08 Jul 2024 for BICYCLE THERAPEUTICS plc, €14k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Nicholas Keen in BICYCLE THERAPEUTICS plc, where the filings describe the role as senior executive. In total, 13 filings cover trades dated from 14 July 2021 to 3 July 2024.
On the market, this insider has only sold: 9 sales, €844k in total. The rest of the record consists of 3 share grants and 1 option exercise. So far in 2024, the count stands at no purchases and 2 sales.
The newest entry dates from 8 July 2024: an open-market sale of €14k, in BICYCLE THERAPEUTICS plc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations